Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.210
+0.100 (2.43%)
At close: Sep 11, 2026, 4:00 PM EDT
4.050
-0.160 (-3.80%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $72.09 million as of September 11, 2026. Its market cap has decreased by -6.62% in one year.
Market Cap
72.09M
Enterprise Value
45.46M
1-Year Change
-6.62%
Ranking
Category
Stock Price
$4.21
ChartMarket Cap Chart
Since September 29, 2003, Alterity Therapeutics's market cap has increased from $29.20M to $72.09M, an increase of 146.87%. That is a compound annual growth rate of 4.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 73.40M | 56.50% |
| Dec 31, 2025 | 46.90M | 62.28% |
| Dec 31, 2024 | 28.90M | 186.14% |
| Dec 29, 2023 | 10.10M | -27.86% |
| Dec 30, 2022 | 14.00M | -44.00% |
| Dec 31, 2021 | 25.00M | 7.76% |
| Dec 31, 2020 | 23.20M | 107.14% |
| Dec 31, 2019 | 11.20M | -1.75% |
| Dec 31, 2018 | 11.40M | -58.99% |
| Dec 29, 2017 | 27.80M | 91.72% |
| Dec 30, 2016 | 14.50M | -62.53% |
| Dec 31, 2015 | 38.70M | -51.69% |
| Dec 31, 2014 | 80.10M | -70.06% |
| Dec 31, 2013 | 267.50M | 307.77% |
| Dec 31, 2012 | 65.60M | 61.98% |
| Dec 30, 2011 | 40.50M | 38.23% |
| Dec 31, 2010 | 29.30M | 9.33% |
| Dec 31, 2009 | 26.80M | -30.03% |
| Dec 31, 2008 | 38.30M | -36.80% |
| Dec 31, 2007 | 60.60M | 55.38% |
| Dec 29, 2006 | 39.00M | 95.98% |
| Dec 30, 2005 | 19.90M | -57.75% |
| Dec 31, 2004 | 47.10M | 43.60% |
| Dec 31, 2003 | 32.80M | 12.33% |
| Sep 29, 2003 | 29.20M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 75.18M |
| OKYO Pharma | 75.05M |
| Gain Therapeutics | 74.63M |
| BioStem Technologies | 74.52M |
| Nutriband | 73.91M |
| NeurAxis | 71.45M |
| Champions Oncology | 70.79M |
| Pliant Therapeutics | 69.97M |